Analysts take a look at Koninklijke Philips N.V. (NYSE:PHG) having this to say.

January 19, 2018 - By Dolores Ford

 Analysts take a look at Koninklijke Philips N.V. (NYSE:PHG) having this to say.

Koninklijke Philips N.V. (NYSE:PHG) Ratings Coverage

Among 13 analysts covering Koninklijke Philips N.V. (NYSE:PHG), 6 have Buy rating, 0 Sell and 7 Hold. Therefore 46% are positive. Koninklijke Philips N.V. had 14 analyst reports since July 28, 2015 according to SRatingsIntel. BNP Paribas downgraded Koninklijke Philips N.V. (NYSE:PHG) on Monday, October 16 to “Neutral” rating. On Wednesday, September 2 the stock rating was upgraded by RBC Capital Markets to “Outperform”. The company was upgraded on Tuesday, July 28 by Societe Generale. The firm has “Hold” rating given on Friday, November 27 by ING Group. Morgan Stanley downgraded Koninklijke Philips N.V. (NYSE:PHG) on Monday, December 12 to “Equal-Weight” rating. As per Tuesday, July 28, the company rating was upgraded by Barclays Capital. The company was upgraded on Wednesday, August 10 by UBS. Natixis downgraded Koninklijke Philips N.V. (NYSE:PHG) on Wednesday, June 21 to “Neutral” rating. Credit Suisse initiated the shares of PHG in report on Tuesday, September 8 with “Outperform” rating. The company was upgraded on Wednesday, October 26 by HSBC. Below is a list of Koninklijke Philips N.V. (NYSE:PHG) latest ratings and price target changes.

16/10/2017 Broker: BNP Paribas Old Rating: Outperform New Rating: Neutral Downgrade

The stock increased 1.96% or $0.7852 during the last trading session, reaching $40.9452. About 611,384 shares traded. Koninklijke Philips N.V. (NYSE:PHG) has risen 38.13% since January 19, 2017 and is uptrending. It has outperformed by 21.43% the S&P500.

Koninklijke Philips N.V. operates as a health technology firm worldwide. The company has market cap of $36.53 billion. It offers diagnostic imaging solutions, magnetic resonance imaging, computed tomography, and diagnostic X-ray; advanced molecular imaging; integrated clinical solutions; and image-guided therapy solutions and therapy devices. It has a 22.06 P/E ratio. The firm also provides enterprise-wide patient monitoring solutions for clinical information at the patientÂ’s bedside; patient analytics and monitoring, and clinical decision support systems; therapeutic care products; respiratory monitoring devices; patient monitoring and therapeutic care consumables; and customer services.

More notable recent Koninklijke Philips N.V. (NYSE:PHG) news were published by: Marketwatch.com which released: “Koninklijke Philips NV ADR” on July 13, 2009, also Valuewalk.com with their article: “Philips Splits Off Lighting In Historic Move” published on September 23, 2014, Investorplace.com published: “Koninklijke Philips NV (ADR) IPO: World’s Largest Light Maker Plans Spinoff” on May 03, 2016. More interesting news about Koninklijke Philips N.V. (NYSE:PHG) were released by: Valuewalk.com and their article: “Philips Intensifies Focus on LED Lighting; Creates Stand-Alone Company” published on July 21, 2014 as well as Marketwatch.com‘s news article titled: “Philips agrees to sell 80% interest in Lumileds” with publication date: December 12, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.